Welcure Drugs & Pharmaceuticals Ltd Aborts Equity Investment & Agro-Pharma Research Lab Project, Completes Export-Sourcing Orders Domestically, Discontinues Procurement Services Mandate

Welcure Drugs & Pharmaceuticals Ltd announced the outcome of its Board of Directors meeting held on December 06, 2025. The company informed about the abortion of the equity investment proposal with Telexcell Trade PTE LTD, Singapore, due to the inability to reach a mutually acceptable framework. The proposed Agro-Pharma Research Laboratory project and fundraising through QIP have been dropped due to strategic priorities. The company completed export-sourcing orders worth INR 299.91 crore through domestic sales to the originally intended parties. A definitive mandate for third-party sourcing and procurement services with Fortune Sagar Impex Company Limited, Thailand, has been discontinued. The meeting commenced at 10:00 AM and concluded at 11:00 AM.